Ligand · 467
467 · N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-2-methyl-N-(2,2,2-trifluoroethyl)-D-alaninamide
467, N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-2-methyl-N-(2,2,2-trifluoroethyl)-D-alaninamide (C17 H15 Cl F4 N6 O, 430.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- 467
- Formula
- C17 H15 Cl F4 N6 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
467 in 2 structures; the first of them:
- 4YTH · Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor… · 467 A4000 · binds LEU855, GLY856, VAL863, ALA880, LYS882, VAL911, MET929, GLU930 and 9 more
- 4YTH · Discovery of vx-509 (decernotinib): a potent and selective janus kinase (JAK) 3 inhibitor… · 467 A4000 · binds LEU855, GLY856, VAL863, ALA880, LYS882, VAL911, MET929, GLU930 and 9 more
Residues it binds most
GLY 2, LEU 2, VAL 2, ALA 2, ARG 2, ASN 2, ASP 2, GLU 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.